We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Analytical Cannabis Logo
Home > Webinars & Online Events > Content Piece

Psychedelics and the Neurobiology of Fast-acting Antidepressants

On Demand

Published: Nov 16, 2021   

Depression is debilitating, yet treatment options are limited. Psychedelics have emerged as potentially impactful drugs with promise of long-lasting beneficial actions. As a result, there are growing efforts to optimize their use in the clinic and to develop next-generation psychedelics with improved pharmacological profiles. One major challenge, however, is that we still do not have a full understanding of how psychedelics work in the brain.

In this seminar, I will describe my lab’s work on fast-acting antidepressants. I will talk about experiments in animal models that have identified cell types and neural plasticity processes involved in ketamine and psilocybin’s actions. I will discuss how the biological insights may lead to novel circuit-level biomarkers, which are crucially needed to accelerate the search for new psychiatric drugs.

During this webinar we will discuss:

  • Ketamine and psilocybin's actions on neural plasticity processes.
  • Biological insights which may lead to novel circuit-level biomarkers.

Watch Now

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter